How (not) to waste a billion dollars (on your clinical trial) — with Meri Beckwith
Development and Research
00:00
Navigating Challenges in Clinical Trials
This chapter examines the hurdles faced by emerging players in the clinical trial landscape, particularly against traditional CROs, and the biases in investor preferences. It emphasizes the need for innovative strategies and adaptive trial methodologies to foster growth and efficiency in biotech. The conversation highlights the regulatory challenges from the FDA that complicate trial designs and the tension between scientific standards and practical execution.
Transcript
Play full episode
